Prescribers are advised that HRT should only be initiated for relief of postmenopausal symptoms that adversely affect quality of life and should be continued only as long as the benefit in alleviating menopause symptoms outweighs the risks associated with HRT use.
In all cases, a careful appraisal of all the risks and benefits should be undertaken before use. These should be reassessed regularly during use as a woman’s need for treatment and risk of adverse effects change over time.